Compounds > valproic acid

valproic acid and aldosterone

valproic acid has been researched along with aldosterone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H1
Strassburg, CP; Tukey, RH1
Cho, HM; Iwasaki, Y; Kim, IK; Kim, SY; Lee, DY; Lee, HA1
Areola, ED; Badmus, OO; Kim, I; Michael, OS; Olatunji, LA; Omolekulo, TE1
Balagova, L; Buzgoova, K; Graban, J; Hlavacova, N; Jezova, D1
Abdulkareem, TO; Adegoke, TE; Adeyanju, OA; Dibia, C; Michael, OS; Olatunji, LA; Omotoye, OO; Oyabambi, AO; Sabinari, IW; Usman, TO1
De Groef, L; Jagomäe, T; Kaasik, A; Kirillov, S; Liiv, M; Moons, L; Plaas, M; Punapart, M; Reimets, R; Seppa, K; Terasmaa, A; Vasar, E1

Reviews

1 review(s) available for valproic acid and aldosterone

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

7 other study(ies) available for valproic acid and aldosterone

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

    Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism

1999
Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
    Circulation research, 2013, Mar-29, Volume: 112, Issue:7

    Topics: Acetylation; Aldosterone; Animals; Desoxycorticosterone; Disease Models, Animal; DNA Polymerase II; Enzyme Inhibitors; Gene Expression; HEK293 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hypertension, Renal; Male; Mineralocorticoids; Nephrectomy; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Transcription, Genetic; Valproic Acid

2013
Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen-progestin.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:11

    Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Aldosterone; Animals; Contraceptives, Oral, Combined; Corticosterone; Disease Models, Animal; Estrogens; Female; Glucose; Humans; Hypertension; Liver; Progestins; Rats; Rats, Wistar; Triglycerides; Uric Acid; Valproic Acid; Xanthine Oxidase

2018
Brain derived neurotrophic factor expression and DNA methylation in response to subchronic valproic acid and/or aldosterone treatment.
    Croatian medical journal, 2019, Apr-30, Volume: 60, Issue:2

    Topics: Aldosterone; Animals; Brain; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Depression; Disease Models, Animal; DNA Methylation; Hippocampus; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Valproic Acid

2019
Allopurinol and valproic acid improve cardiac triglyceride and Na
    Archives of physiology and biochemistry, 2022, Volume: 128, Issue:5

    Topics: Adenosine Triphosphatases; Aldosterone; Allopurinol; Animals; Contraceptives, Oral, Combined; Female; Glucose Intolerance; Humans; Insulin Resistance; Levonorgestrel; Nitric Oxide; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Triglycerides; Valproic Acid

2022
The Expression of RAAS Key Receptors,
    Genes, 2021, 10-28, Volume: 12, Issue:11

    Topics: Aldosterone; Animals; Calmodulin-Binding Proteins; Cells, Cultured; Disease Models, Animal; Down-Regulation; Gene Knockout Techniques; Liraglutide; Male; Membrane Proteins; Rats; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B1; Renin-Angiotensin System; Valproic Acid; Wolfram Syndrome

2021